Cholecystokinin receptor subtypes and neuromodulation
Data up to Jan 2025
Total Citations Per Year
Abstract
References (43)
Statistical principles in experimental design.
1962 • 27,228 citations
Statistical Principles in Experimental Design
1964 • 8,376 citations
Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
1986 • 2,110 citations
Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
1986 • 1,751 citations
Psychopharmacology: A Generation of Progress
1979 • 1,101 citations
The Dopamine Hypothesis of Schizophrenia: A Review*
1976 • 862 citations
Two brain cholecystokinin receptors: implications for behavioral actions
1986 • 719 citations
Evidence for coexistence of dopamine and CCK in meso-limbic neurones
1980 • 696 citations
Amphetamine Psychosis: A "Model" Schizophrenia Mediated by Catecholamines
1973 • 590 citations
Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.
1986 • 544 citations
Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists
1987 • 331 citations
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.
1986 • 322 citations
Autoradiographic localization of cholecystokinin receptors in rodent brain
1983 • 259 citations
Rapid appearance of intraventricularly administered neuropeptides in the peripheral circulation
1982 • 224 citations
Dopamine release in vivo from nigrostriatal, mesolimbic, and mesocortical neurons: utility of 3-methoxytyramine measurements.
1988 • 207 citations
Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia
1983 • 164 citations
Biochemical investigation on the localization of the cholecystokinin octapeptide in dopaminergic neurons originating from the ventral tegmental area of the rat
1981 • 140 citations
Origin of the Cholecystokinin-Containing Fibers in the Rat Caudatoputamen
1982 • 132 citations
Characterization of the binding of [3H]-(+/-)-L-364,718: a new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors.
1986 • 120 citations
Distribution of cholecystokinin (CCK) in the hypothalamus and limbic system of the rat
1981 • 116 citations
Estimation of the Turnover of 3‐Methoxytyramine in the Rat Striatum by HPLC with Electrochemical Detection: Implications for the Sequence in the Cerebral Metabolism of Dopamine
1982 • 105 citations
The origin of cholecystokinin terminals in the basal forebrain of the rat: Evidence from immunofluorencence and retrograde tracing
1983 • 96 citations
Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtype
1986 • 93 citations
Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy
1982 • 90 citations
Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbens using intracerebral dialysis in the anaesthetized rat
1987 • 83 citations
Cholecystokinin octapeptide levels in rat brain are changed after subchronic neuroleptic treatment
1983 • 77 citations
In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens
1986 • 73 citations
Brain CCK receptors are structurally distinct from pancreas CCK receptors
1984 • 73 citations
Reduced high affinity cholecystokinin binding in hippocampus and frontal cortex of schizophrenic patients
1985 • 72 citations
Cholecystokinin and Schizophrenia
1986 • 70 citations
Effect of 6-hydroxydopamine lesions of the medial forebrain bundle on the distribution of cholecystokinin in rat forebrain
1982 • 68 citations
A selected ion monitoring assay for dopamine and its metabolites using negative chemical ionization
1982 • 68 citations
Cholecystokinin, dopamine and schizophrenia
1984 • 60 citations
The effects of cholecystokinin on the in vivo release of newly synthesized [3H]dopamine from the nucleus accumbens of the rat
1985 • 55 citations
Characterization of central cholecystokinin receptors using a radioiodinated octapeptide probe
1985 • 50 citations
Sensorimotor impairment and elevated levels of dopamine metabolites in the neostriatum occur rapidly after intranigral injection of 6-hydroxydopamine or gamma-hydroxybutyrate in awake rats
1984 • 47 citations
Electrophysiological studies on the specificity of the cholecystokinin antagonist proglumide
1987 • 47 citations
Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine release
1988 • 44 citations
Localization of cholecystokinin receptors on neuronal elements in rat caudate nucleus
1981 • 36 citations
Localization of cholecystokinin receptors in relation to the nigrostriatal and mesolimbic dopaminergic pathways
1987 • 21 citations
Bilateral subdiaphragmatic vagotomy does not prevent the behavioral effects of systematically administered ceruletide in mice
1987 • 21 citations
Reversal by cholecystokinin of apomorphine-induced inhibition of dopamine release in the nucleus accumbens of the rat
1987 • 17 citations
Cholecystokinin: a neuropeptide in the treatment of schizophrenia.
1986 • 11 citations